Birdwatch Archive

Birdwatch Note Rating

2024-05-07 07:01:07 UTC - HELPFUL

Rated by Participant: E9742E483D534B82C86E99CB2E98EDEB4F98B6DDF128ACD1A6AAF8FDA5944C25
Participant Details

Original Note:

Der Widerruf erfolgte auf Antrag von AstraZeneca selbst, nicht wegen Nebenwirkungen: "Auf Antrag des Zulassungsinhabers wird die (...) erteilte Zulassung des Arzneimittels "Vaxzevria - COVID‑19‑Impfstoff (ChAdOx1‑S [rekombinant])" widerrufen." https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_de.pdf

All Note Details

Original Tweet

All Information

  • noteId - 1787722639034769889
  • participantId -
  • raterParticipantId - E9742E483D534B82C86E99CB2E98EDEB4F98B6DDF128ACD1A6AAF8FDA5944C25
  • createdAtMillis - 1715065267546
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1787722639034769889E9742E483D534B82C86E99CB2E98EDEB4F98B6DDF128ACD1A6AAF8FDA5944C25